Hi, what are you looking for?
Jewish Business News
Search results for "BiondVax "
Business
BiondVax, the developer of the universal flu vaccine, progresses towards Phase 3 clinical trials and construction of its commercial manufacturing facility; The Company also...
Business
The universal flu vaccine is designed to provide multi-season protection against most seasonal and pandemic human influenza virus strains.
Business
BiondVax Pharmaceuticals Ltd. has announce that Angels High Tech Investments Ltd. has agreed to invest NIS 10.9 million, (approx $2.83 million), in exchange...
Business
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) received the statistical analysis of results from a study which demonstrates that BiondVax’s universal flu vaccine...
StartUps
– – Israeli firm BiondVax, a biopharmaceutical company developing a Universal Flu Vaccine, announced that its Investigational New Drug Application (IND) for its Multimeric-001...
IPOs
– BiondVax is exploring two options – either a conventional offering or listing American Depositary Receipts. – Universal flu vaccine developer BiondVax Pharmaceuticals...
StartUps
Israeli firm BiondVax, a biopharmaceutical company developing a Universal Flu Vaccine, has been awarded $1.34 million from Israel’s Chief Scientist in the Ministry of...
StartUps
– Press Release BiondVax’s universal flu vaccine matches all 6 potentially pandemic flu strains in the world today: H5N1, H5N8, H6N1, H7N7, H7N9...
Life-Style Health
Most European nations, the U.S., Israel and the Gulf states are expected to have vaccinated 60-70 percent of their adult populations by the end...
VC, Investments
With $1 billion assets under management, Israeli health-tech venture capital aMoon has raised $660 million in commitments to its second fund aMoon2, making it the largest...